This scholarship page was last updated on 31 March 2021. Some details may have changed since then. Please check the Department of Health and Human Services National Institutes of Health website or the Department of Health and Human Services National Institutes of Health page for current opportunities.

Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial Not Allowed)

Department of Health and Human Services National Institutes of Health
Tipo

Research/project funding

Posted on:

Scadenza delle domande:

Expired

Reference Number

RFA-HG-21-007

This Funding Opportunity Announcement (FOA) solicits R21 grant applications to innovate and develop the early stages of novel technologies that will enable greater than a one order of magnitude improvement in 1) DNA sequencing, and 2) methods for direct sequencing of the diversity of entire RNA molecules. Advances in genomics and more broadly in biomedical research have been greatly facilitated by cycles of technology innovation and disruption that have driven significant and sustained nucleic acid sequencing throughput and assembly quality increases combined with cost decreases and quality improvements. The goal now is to dramatically advance DNA sequencing and direct RNA sequencing technologies at reasonable costs with the anticipation that significant exploratory innovation in any of these and related areas would make significant contributions to the mission of NHGRI and the field of genomics, including to many of NHGRIs other technology development goals
Categories: Health.

More Information

Tipo

Research/Project Funding

Posted on:

Scadenza delle domande:

Expired

Reference Number

RFA-HG-21-007

Stati Uniti